Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven D Pearson

Showing results (141-150 of 169) with videos related to

Pageof 17
Sort By:
Journal of Managed Care & Specialty Pharmacy|June 2, 2024
Iptacopan and danicopan for paroxysmal nocturnal hemoglobinuriaShahariar Mohammed Fahim, Anil N Makam, Kangho Suh, et al.
Journal of Managed Care & Specialty Pharmacy|November 28, 2018
Cost-Effectiveness of Targeted Pharmacotherapy for Moderate to Severe Plaque PsoriasisNathaniel Hendrix, Daniel A Ollendorf, Richard H Chapman, et al.
Journal of Managed Care & Specialty Pharmacy|April 30, 2023
Medications for obesity management: Effectiveness and valueSteven J Atlas, Kibum Kim, Emily Nhan, et al.
Journal of Managed Care & Specialty Pharmacy|May 27, 2022
The effectiveness and value of tirzepatide for type 2 diabetes mellitusDmitriy Nikitin, Grace A Lin, Jon D Campbell, et al.
Journal of Managed Care & Specialty Pharmacy|December 24, 2021
JAK inhibitors and monoclonal antibodies for the treatment of atopic dermatitis: effectiveness and valueFoluso Agboola, Steven J Atlas, Elizabeth Brouwer, et al.
JAMA Network Open|February 23, 2019
Long-term Survival and Cost-effectiveness Associated With Axicabtagene Ciloleucel vs Chemotherapy for Treatment of B-Cell LymphomaMelanie D Whittington, R Brett McQueen, Daniel A Ollendorf, et al.
Journal of Managed Care & Specialty Pharmacy|June 5, 2023
The effectiveness and value of fezolinetant for moderate-to-severe vasomotor symptoms associated with menopause: A summary from the Institute for Clinical and Economic Review's Midwest Public Advisory CouncilAbigail C Wright, Francesca L Beaudoin, R Brett McQueen, et al.
JAMA Pediatrics|October 11, 2018
Long-term Survival and Value of Chimeric Antigen Receptor T-Cell Therapy for Pediatric Patients With Relapsed or Refractory LeukemiaMelanie D Whittington, R Brett McQueen, Daniel A Ollendorf, et al.
Journal of Managed Care & Specialty Pharmacy|June 2, 2024
KarXT for schizophrenia-effectiveness and value: A summary from the Institute for Clinical and Economic Review's New England Comparative Effectiveness Public Advisory CouncilAvery McKenna, Jeffrey A Tice, Melanie D Whittington, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 4, 2022
The Cost-Effectiveness of Belimumab and Voclosporin for Patients with Lupus Nephritis in the United StatesOlena Mandrik, James Fotheringham, Shijie Ren, et al.
Pageof 17

Showing results (141-150 of 169) with videos related to

Sort By:
Pageof 17
Journal of Managed Care & Specialty Pharmacy|June 2, 2024
Iptacopan and danicopan for paroxysmal nocturnal hemoglobinuriaShahariar Mohammed Fahim, Anil N Makam, Kangho Suh, et al.
Journal of Managed Care & Specialty Pharmacy|November 28, 2018
Cost-Effectiveness of Targeted Pharmacotherapy for Moderate to Severe Plaque PsoriasisNathaniel Hendrix, Daniel A Ollendorf, Richard H Chapman, et al.
Journal of Managed Care & Specialty Pharmacy|April 30, 2023
Medications for obesity management: Effectiveness and valueSteven J Atlas, Kibum Kim, Emily Nhan, et al.
Journal of Managed Care & Specialty Pharmacy|May 27, 2022
The effectiveness and value of tirzepatide for type 2 diabetes mellitusDmitriy Nikitin, Grace A Lin, Jon D Campbell, et al.
Journal of Managed Care & Specialty Pharmacy|December 24, 2021
JAK inhibitors and monoclonal antibodies for the treatment of atopic dermatitis: effectiveness and valueFoluso Agboola, Steven J Atlas, Elizabeth Brouwer, et al.
JAMA Network Open|February 23, 2019
Long-term Survival and Cost-effectiveness Associated With Axicabtagene Ciloleucel vs Chemotherapy for Treatment of B-Cell LymphomaMelanie D Whittington, R Brett McQueen, Daniel A Ollendorf, et al.
Journal of Managed Care & Specialty Pharmacy|June 5, 2023
The effectiveness and value of fezolinetant for moderate-to-severe vasomotor symptoms associated with menopause: A summary from the Institute for Clinical and Economic Review's Midwest Public Advisory CouncilAbigail C Wright, Francesca L Beaudoin, R Brett McQueen, et al.
JAMA Pediatrics|October 11, 2018
Long-term Survival and Value of Chimeric Antigen Receptor T-Cell Therapy for Pediatric Patients With Relapsed or Refractory LeukemiaMelanie D Whittington, R Brett McQueen, Daniel A Ollendorf, et al.
Journal of Managed Care & Specialty Pharmacy|June 2, 2024
KarXT for schizophrenia-effectiveness and value: A summary from the Institute for Clinical and Economic Review's New England Comparative Effectiveness Public Advisory CouncilAvery McKenna, Jeffrey A Tice, Melanie D Whittington, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 4, 2022
The Cost-Effectiveness of Belimumab and Voclosporin for Patients with Lupus Nephritis in the United StatesOlena Mandrik, James Fotheringham, Shijie Ren, et al.
Pageof 17